论文部分内容阅读
我科自1986年以来采用碘油混合抗癌药物治疗肝癌17例,现将治疗情况报告如下。 一、一般情况 本组17例均为男性,年龄23～64岁,平均年龄40.7岁。所有病例均经B超、CT、及肝动脉造影等检查以确定肿瘤部位,肿瘤位于肝右叶者9例,位于左叶者1例,左右两叶均有者4例,伴肺转移者1例,伴肺、脑转移者1例;肿瘤直径5～10cm9例,10cm以上8例。AFP检查:<25μg/L 4例,50～10001μg/L 11例,1000μg/L以上2例。GPT检查:41～80u/L 8例,其余9例正常。所有病例治疗前均无黄疸及腹水。
Since 1986, our department has used lipiodol mixed anti-cancer drugs to treat 17 cases of liver cancer. Now we report the treatment as follows. First, the general situation of this group of 17 cases were all men, aged 23 to 64 years, mean age 40.7 years. All cases were examined by B-ultrasonography, CT, and hepatic artery angiography to determine the tumor site. The tumor was located in the right lobe of the liver in 9 cases, in the left lobe in 1 case, in the left and right lobes in 4 cases, with lung metastasis 1 For example, there were 1 case with lung and brain metastasis; tumor diameter was 5 to 10cm in 9 cases, and 10cm in 8 cases. AFP examination: <25μg/L in 4 cases, 50 to 10001μg/L in 11 cases, and 1000μg/L in 2 cases. GPT examination: 41 to 80u/L in 8 cases, and the remaining 9 cases were normal. All cases had no jaundice and ascites before treatment.